The Effects of Omega-3 Fatty Acids on Aspirin Resistance (NCT00771914) | Clinical Trial Compass
CompletedPhase 1/2
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
United States27 participantsStarted 2008-11
Plain-language summary
The purpose of this study is to determine if omega-3 fatty acids enhance the antiplatelet effects of aspirin.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Willing to participate by providing informed consent and committing to complete the study. This includes adhering to the study diet.
* No chronic disease by history and based on a complete blood count and comprehensive metabolic profile.
* Commitment to not taking aspirin, non-steroidal anti-inflammatory medications, and to limit fish intake to ≤2 meals during the 7 days prior to each CRC study period. They will also need to abstain from taking a list of over-the-counter medications that include aspirin. For the duration of the study, they will also be asked to abstain from taking fish and flax seed oil supplements.
Exclusion Criteria:
* Reports the presence of chronic disease (e.g. cardiovascular, renal, hepatic, neurodegenerative, neoplastic, metabolic {diabetes}, hypertension).
* Reports taking a systemic medication chronically.
* History of serious adverse reaction or allergy to aspirin or fish oil.
* Baseline platelet count \<100 000 or \>500 000, hematocrit \<30%, or white blood cell count \>20 000.
* Any abnormality from a screening CBC and complete blood count that suggests acute or chronic disease.
* Nicotine user.
* History of alcohol abuse
* Pregnancy by history or urine/serum pregnancy test
* History of intestinal malabsorption syndrome including gastric bypass surgery
What they're measuring
1
the Difference Between the Time to Clot Formation in Seconds at Baseline and After Each Treatment